Insider Transactions in Q2 2018 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q2 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 29
2018
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
69,444
+7.16%
|
$1,249,992
$18.0 P/Share
|
|
May 29
2018
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
830,999
+50.0%
|
-
|
|
May 29
2018
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
843,352
+26.44%
|
$16,023,688
$19.49 P/Share
|
|
May 29
2018
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
383,538
+50.0%
|
-
|
|
May 29
2018
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
3,000,000
+50.0%
|
$54,000,000
$18.0 P/Share
|